poor prospects, page-3

freddifish,
IMO cmq had no choice - nobody could make it. So which is safer IP - an easy to make product or a hard to make product?

maybe your post should be on the imu board, might get the volume up?

So when big pharma takes imu invention, how much will shareholders have left?

neo
PS both cmq and imu shareholders are at the mercy of devil they need.